Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 285

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 285
---
Accounts receivable

In order to minimize the
credit risk, the management of the Company monitors and ensures that follow-up action is taken to recover overdue debts. The Company
considers the probability of default upon initial recognition of asset and whether there has been a significant increase in credit risk
on an ongoing basis throughout each reporting period. To assess whether there is a significant increase in credit risk, the Company compares
the risk of a default occurring on the asset as at the reporting date with the risk of default as at the date of initial recognition.
It considers available reasonable and supportive forward-looking information, such as GDP growth rate and nominal GDP per capita.
Based on the impairment assessment performed by the Company, the directors consider the loss allowance for account receivables as of
June 30, 2025 and December 31, 2024 to be $19.

Cash and cash equivalents

The credit risk on liquid
funds is limited because the counterparties are banks with high credit ratings assigned by international credit-rating agencies.
The Company is exposed to concentration of credit risk on liquid funds which are deposited with several banks with high credit ratings.

Deposits and other receivables, amount due from shareholders and loan to A SPAC I

The Company assessed the
impairment for deposits and other receivables, due from shareholders individually based on internal credit rating and ageing of these
debtors which, in the opinion of the directors, have no significant increase in credit risk since initial recognition. Based on the impairment
assessment performed by the Company, the directors consider the loss allowance for deposits and other receivables, due from shareholders
as of June 30, 2025 and December 31, 2024 is $0, and $14, respectively. The loss allowance for deposits and other receivables, due
from shareholders as of June 30, 2025 and December 31, 2024 is $0, and $14, respectively.

B. Interest
risk

Cash flow interest rate risk

The Company is exposed to
cash flow interest rate risk through the changes in interest rates related mainly to the Company’s variable-rates bank balances.

The Company currently does
not have any interest rate hedging policy in relation to fair value interest rate risk and cash flow interest rate risk. The directors
monitor the Company’s exposures on an ongoing basis and will consider hedging the interest rate should the need arises.

<div align='center'>F-61</div>

Sensitivity analysis

The